Loading asset research
Cingulate Inc. Common Stock
CINGNasdaq · USD · StocksQuote as of · Exchange session not verified$5.04
-2.51%
Today
CING
Loading 1D prices…
Market cap
$73M
Volume
99.6K
52w high
$11.8952w low
$3.16Company profile
Cingulate Inc. Common Stock
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
KANSAS CITY, KS, United States
Employees
14
Fiscal year end
1231
CIK
1862150
Session & valuation
Open$5.22
Previous close$5.17
Day high$5.28
Day low$5.02
30-day avg. volume137.5K
Outstanding shares14.5M
Diluted EPS-$4.44
Latest annual period
P/E (trailing)-1.14
P/E (forward)-5.70
Price / book2.97
Beta-0.89
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ZYBTZhengye Biotechnology Holding Limited Class A Ordinary Shares | $73.5M | $16.6M | -59.99% | $0.25 | -2.52% | Unrated |
| PLRXPliant Therapeutics Inc. Common Stock | $72.4M | $0.00 | — | -$2.43 | +3.54% | Sell |
| ATHEAlterity Therapeutics Limited American Depositary Shares | $73.7M | — | — | -$1.33 | -1.22% | Buy |
| YARWYarrow Bioscience Inc. Common Stock | $72.1M | $570K | -4646.14% | -$0.62 | -5.03% | Hold |
| PMVPPMV Pharmaceuticals Inc. Common Stock | $74.8M | $0.00 | — | -$1.48 | -1.39% | Buy |